Last updated: August 27, 2025
Sponsor: Kansas City Heart Rhythm Research Foundation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chest Pain
Thrombosis
Arrhythmia
Treatment
Left Atrial Appendage Occlusion
Clinical Study ID
NCT06075628
KCHRRF_CF-CT Registry_0021
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subjects must be at least 18 years of age.
Subjects underwent LAA closure with Watchman/Watchman FLX or Amplatzer Amulet at ourinstitution from January 2019 till June 2022
Exclusion
Exclusion Criteria:
- No definite exclusion criteria are defined for the study as all patients withWatchman-FLX or Amplatzer Amulet will be included in the study.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Left Atrial Appendage Occlusion
Phase:
Study Start date:
July 24, 2023
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Kansas City Heart Rhythm Institute
Overland Park, Kansas 66211
United StatesSite Not Available
Kansas City Heart Rhythm Institute - Roe Clinic
Overland Park, Kansas 66211
United StatesSite Not Available
Overland Park Regional Medical Center
Overland Park, Kansas 66215
United StatesSite Not Available
Kansas City Heart Rhythm Institute
Overland Park 4276873, Kansas 4273857 66211
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.